BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31814332)

  • 1. A Tumor Microenvironment-Responsive Biodegradable Mesoporous Nanosystem for Anti-Inflammation and Cancer Theranostics.
    Wu J; Niu S; Bremner DH; Nie W; Fu Z; Li D; Zhu LM
    Adv Healthc Mater; 2020 Jan; 9(2):e1901307. PubMed ID: 31814332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomineralized Bimetallic Oxide Nanotheranostics for Multimodal Imaging-Guided Combination Therapy.
    Wu J; Williams GR; Niu S; Yang Y; Li Y; Zhang X; Zhu LM
    Theranostics; 2020; 10(2):841-855. PubMed ID: 31903154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemodrug-Gated Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Multimodal Imaging-Guided Low-Temperature Photothermal Therapy/Chemotherapy of Cancer.
    Wu J; Bremner DH; Niu S; Shi M; Wang H; Tang R; Zhu LM
    ACS Appl Mater Interfaces; 2018 Dec; 10(49):42115-42126. PubMed ID: 30462492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BSA-IrO
    Zhen W; Liu Y; Lin L; Bai J; Jia X; Tian H; Jiang X
    Angew Chem Int Ed Engl; 2018 Aug; 57(32):10309-10313. PubMed ID: 29888846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.
    Deng X; Zhao R; Song Q; Zhang Y; Zhao H; Hu H; Zhang Z; Liu W; Lin W; Wang G
    Drug Deliv; 2022 Dec; 29(1):3142-3154. PubMed ID: 36164704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-in-One Theranostic Nanoplatform Based on Hollow MoS
    Wang J; Liu L; You Q; Song Y; Sun Q; Wang Y; Cheng Y; Tan F; Li N
    Theranostics; 2018; 8(4):955-971. PubMed ID: 29463993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pd@Au Bimetallic Nanoplates Decorated Mesoporous MnO
    Zhang Y; Lv F; Cheng Y; Yuan Z; Yang F; Liu C; Cao Y; Zhang K; Lu H; Zada S; Guo S; Dong H; Zhang X
    Adv Healthc Mater; 2020 Jan; 9(2):e1901528. PubMed ID: 31820854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable nanotheranostics with hyperthermia-induced bubble ability for ultrasound imaging-guided chemo-photothermal therapy.
    Xu C; Gao F; Wu J; Niu S; Li F; Jin L; Shi Q; Du L
    Int J Nanomedicine; 2019; 14():7141-7153. PubMed ID: 31564870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin-bioinspired iridium oxide nanoplatform with high photothermal conversion efficiency for synergistic chemo-photothermal of osteosarcoma.
    Gu W; Zhang T; Gao J; Wang Y; Li D; Zhao Z; Jiang B; Dong Z; Liu H
    Drug Deliv; 2019 Dec; 26(1):918-927. PubMed ID: 31526064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment activated mussel-inspired hollow mesoporous nanotheranostic for enhanced synergistic photodynamic/chemodynamic therapy.
    Tian Yan H; Jang MS; Liu C; Fu Q; Wang B; Fu Y; Hee Lee J; Yu Yang H
    J Colloid Interface Sci; 2024 Jul; 665():188-203. PubMed ID: 38522159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate receptor-targeted theranostic IrS
    Zhang DY; Zheng Y; Zhang H; Yang GG; Tan CP; He L; Ji LN; Mao ZW
    Nanoscale; 2018 Dec; 10(47):22252-22262. PubMed ID: 30465053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect.
    Dong Y; Dong S; Wang Z; Feng L; Sun Q; Chen G; He F; Liu S; Li W; Yang P
    ACS Appl Mater Interfaces; 2020 Nov; 12(47):52479-52491. PubMed ID: 33196186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of iridium-based nanocomposite with catalase activity for cancer phototherapy.
    Wu H; Jiang Q; Luo K; Zhu C; Xie M; Wang S; Fei Z; Zhao J
    J Nanobiotechnology; 2021 Jul; 19(1):203. PubMed ID: 34233696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals.
    Li R; Hu X; Shang F; Wu W; Zhang H; Wang Y; Pan J; Shi S; Dong C
    Acta Biomater; 2022 Aug; 148():218-229. PubMed ID: 35705171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BSA-templated synthesis of Ir/Gd bimetallic oxide nanotheranostics for MR/CT imaging-guided photothermal and photodynamic synergistic therapy.
    Cai C; Tian F; Ma J; Yu Z; Yang M; Yi C
    Nanoscale; 2023 Mar; 15(9):4457-4468. PubMed ID: 36752324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and
    Shao L; Li Y; Huang F; Wang X; Lu J; Jia F; Pan Z; Cui X; Ge G; Deng X; Wu Y
    Theranostics; 2020; 10(16):7273-7286. PubMed ID: 32641992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interface-Engineered Paclitaxel-Based Hollow Mesoporous Organosilica Nanoplatforms for Photothermal-Enhanced Chemotherapy of Tumor.
    Qian C; Al-Hamyari B; Tang X; Hou B; Yang S; Zhang G; Lv H; Yang Z; Wang Z; Shi Y
    Mol Pharm; 2021 Dec; 18(12):4531-4542. PubMed ID: 34739255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.